Patents by Inventor Sherry A. Shapiro

Sherry A. Shapiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MCH antagonists for the treatment of obesity
    Patent number: 7345042
    Abstract: The present invention discloses methods of using antagonists for melanin-concentrating hormone (MCH), to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes, as well as novel compounds which are antagonists for melanin-concentrating hormone (MCH). In other aspects, the invention is directed to pharmaceutical compositions comprising such MCH antagonists as well as methods for preparing such compounds. Compounds of the invention generally have the structure: where the substituents are as defined herein.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: March 18, 2008
    Assignee: Schering Corporation
    Inventors: Anandan Palani, Sherry A. Shapiro, Hubert B. Josien, Thomas A. Bara, John W. Clader, Pradeep B. Pushpavanam, Shengjian Li, Mark D. McBriar
  • MCH antagonists for the treatment of obesity
    Patent number: 7045636
    Abstract: The present invention discloses compounds, which are novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: May 16, 2006
    Assignee: Schering Corporation
    Inventors: Anandan Palani, Sherry A. Shapiro, Mark D. McBriar, Jing Su
  • MCH antagonists for the treatment of obesity
    Publication number: 20030144261
    Abstract: The present invention discloses compounds, which are novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
    Type: Application
    Filed: October 23, 2002
    Publication date: July 31, 2003
    Applicant: Schering Corporation
    Inventors: Anandan Palani, Sherry A. Shapiro, Mark D. McBriar, Jing Su
  • MCH antagonists and their use in the treatment of obesity
    Publication number: 20030022891
    Abstract: The present invention related to compounds of the formula 1
    Type: Application
    Filed: November 28, 2001
    Publication date: January 30, 2003
    Inventors: Anandan Palani, Mark D. McBriar, Sherry A. Shapiro, Ruo Xu, John Clader